Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Infinera | INFN | May 20, 2024 | 5.34 | +1.52 |
InFinT Acquisition | IFIN | May 20, 2024 | 11.50 | 0.00 |
InflaRx N.V | IFRX | May 20, 2024 | 1.54 | -5.52 |
Inflection Point Acquisition II | IPXX | May 20, 2024 | 10.52 | -0.05 |
Inflection Point Acquisition II Unit | IPXXU | May 20, 2024 | 10.55 | +0.48 |
Infobird | IFBD | May 20, 2024 | 3.95 | +7.92 |
Informatica | INFA | May 20, 2024 | 30.59 | +3.62 |
Information Services Group | III | May 20, 2024 | 3.15 | +0.64 |
Information Technology ETF Vanguard | VGT | May 20, 2024 | 539.30 | +1.27 |
Infosys ADR | INFY | May 20, 2024 | 17.13 | 0.00 |
InfuSystems | INFU | May 20, 2024 | 6.49 | +0.78 |
ING Group ADR | ING | May 20, 2024 | 17.87 | -0.61 |
Ingersoll Rand | IR | May 20, 2024 | 94.14 | +1.61 |
Ingevity | NGVT | May 20, 2024 | 51.03 | -4.71 |
Ingles Markets A | IMKTA | May 20, 2024 | 73.48 | -3.21 |
Ingredion | INGR | May 20, 2024 | 118.23 | -1.17 |
Inhibikase Therapeutics | IKT | May 20, 2024 | 1.86 | +7.51 |
Inhibrx | INBX | May 20, 2024 | 34.46 | -0.69 |
InMed | INM | May 20, 2024 | 0.33 | +10.55 |
InMode | INMD | May 20, 2024 | 19.00 | +2.93 |
INmune Bio | INMB | May 20, 2024 | 11.23 | +3.50 |
Innate Pharma ADR | IPHA | May 20, 2024 | 2.85 | +5.17 |
Inno Holdings | INHD | May 20, 2024 | 0.59 | -2.46 |
Innodata | INOD | May 20, 2024 | 12.21 | +1.67 |
Innospec | IOSP | May 20, 2024 | 129.07 | -0.33 |
InnovAge | INNV | May 20, 2024 | 4.31 | +16.49 |
Innovate | VATE | May 20, 2024 | 0.73 | -4.72 |
Innovative Eyewear | LUCY | May 20, 2024 | 0.19 | -4.60 |
Innovative Industrial Properties | IIPR | May 20, 2024 | 112.84 | -0.96 |
Innovative Industrial Properties A Pref | IIPR-A | May 20, 2024 | 26.91 | -0.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.